The purpose of this study is to investigate the use of non-invasive positive pressure ventilation (NIPPV) in children who have undergone allogeneic hematopoietic cell transplantation (HCT). Allogeneic HCT is a procedure where a patient receives blood-forming stem cells from a genetically similar, but not identical, donor. This study aims to identify factors that may lead to the failure of NIPPV in these patients.
Participants in this study may undergo procedures related to monitoring the effectiveness of NIPPV. Non-invasive positive pressure ventilation is a method that helps patients breathe without the need for a tube inserted into their airway. It involves a mask or similar device that provides air pressure to keep airways open.
- Who can participate: Participants are children aged X to Y who have undergone allogeneic hematopoietic cell transplantation.
- Study details: Participants will be monitored to assess the effectiveness of non-invasive positive pressure ventilation. This involves using a mask or similar device to assist with breathing. If applicable, a placebo, an inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine, may be used.
